Stem Cell Therapy for Cerebral Palsy
Phase 1
Withdrawn
- Conditions
- Cerebral Palsy
- Registration Number
- NCT01978821
- Lead Sponsor
- Neurogen Brain and Spine Institute
- Brief Summary
the purpose of this study was to study the effect of stem cell therapy on common symptoms of cerebral palsy patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Diagnosed cases of any type of Cerebral Palsy
- age above 12 months.
Exclusion Criteria
- presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus
- malignancies
- bleeding tendencies
- pneumonia
- renal failure
- severe liver dysfunction
- severe anemia [Hemoglobin < 8]
- any bone marrow disorder
- space occupying lesion in brain
- other acute medical conditions such as respiratory infection and pyrexia.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Change in clinical symptoms of cerebral palsy after 6 months Six months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie autologous bone marrow mononuclear cell therapy in cerebral palsy?
How does autologous bone marrow mononuclear cell transplantation compare to standard-of-care treatments for cerebral palsy in clinical outcomes?
Which biomarkers are associated with response to autologous bone marrow mononuclear cell therapy in cerebral palsy patients?
What are the known or potential adverse events of autologous bone marrow mononuclear cell transplantation in cerebral palsy trials?
Are there any combination therapies or alternative stem cell sources being explored alongside autologous bone marrow mononuclear cells for cerebral palsy treatment?
Trial Locations
- Locations (1)
Neurogen brain and spine institute
🇮🇳Mumbai, Maharashtra, India
Neurogen brain and spine institute🇮🇳Mumbai, Maharashtra, India